{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:00:15Z","timestamp":1760238015112,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009422","name":"National PKU Alliance","doi-asserted-by":"publisher","award":["Research Grant 2018"],"award-info":[{"award-number":["Research Grant 2018"]}],"id":[{"id":"10.13039\/100009422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Perinatal stem cells and epithelial cells isolated from full term amnion membrane, in particular, have attracted interest over the last decade, as a promising source of multipotent cells for cellular therapies. Human amnion epithelial cells (hAEC) have been used to treat monogenetic liver disease such as maple syrup urine disease or fibrosis of the liver in preclinical studies. In most studies xeno-transplants of hAEC were conducted without providing immunosuppression to recipients, reflecting the tolerogenic properties of hAEC. For many cell types, successful cryopreservation is critical for providing a readily available, off-the-shelf product. In this study, hAEC were isolated from full-term human placenta from 14 different donors, cryopreserved using a protocol and reagents commonly adopted for epithelial cell preservation. The cells were analyzed in terms of survival, recovery, and homogeneity, profiled for surface markers characteristic of epithelial, mesenchymal, endothelial, or hematopoietic cells. There were no significant differences observed in the percentage of cells with epithelial cell markers before and after cryopreservation. The relative proportion of stromal and hematopoietic cells was significantly reduced in hAEC preparations after cryopreservation. The expression of stem cell and immunomodulatory molecules were confirmed in the final product. Since multipotent cells are readily available from full-term placenta, this novel cell source might significantly increase the number of patients eligible to receive cellular therapies for liver and other diseases.<\/jats:p>","DOI":"10.3390\/cells9071696","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T06:38:55Z","timestamp":1595313535000},"page":"1696","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Cryogenic Storage on Human Amnion Epithelial Cells"],"prefix":"10.3390","volume":"9","author":[{"given":"Raghuraman C.","family":"Srinivasan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, 141 52 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Strom","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, 141 52 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gramignoli","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, 141 52 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5966\/sctm.2015-0304","article-title":"A Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases","volume":"5","author":"Miki","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1095\/biolreprod.106.055244","article-title":"Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential","volume":"77","author":"Ilancheran","year":"2007","journal-title":"Boil. Reprod."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1247\/csf.29.73","article-title":"Human amniotic epithelial cells possess hepatocyte-like characteristics and functions","volume":"29","author":"Takashima","year":"2004","journal-title":"Cell Struct. Funct."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem Cell Characteristics of Amniotic Epithelial Cells","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cells"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.24255","article-title":"Hepatic differentiation of amniotic epithelial cells","volume":"53","author":"Marongiu","year":"2011","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3727\/000000003108747000","article-title":"Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice","volume":"12","author":"Wei","year":"2003","journal-title":"Cell Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3727\/096368912X653039","article-title":"In Vivo Differentiation of Human Amniotic Epithelial Cells into Cardiomyocyte-Like Cells and Cell Transplantation Effect on Myocardial Infarction in Rats: Comparison with Cord Blood and Adipose Tissue-Derived Mesenchymal Stem Cells","volume":"21","author":"Fang","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2492\/inflammregen.31.256","article-title":"The emergence of amnion epithelial stem cells for the treatment of Multiple Sclerosis","volume":"31","author":"McDonald","year":"2011","journal-title":"Inflamm. Regen."},{"key":"ref_9","first-page":"1551","article-title":"Shielding islets with human amniotic epithelial cells enhances islet engraftment and revascularization in a murine diabetes model","volume":"20","author":"Lebreton","year":"2020","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1164\/rccm.201001-0014OC","article-title":"Human Amnion Epithelial Cell Transplantation Abrogates Lung Fibrosis and Augments Repair","volume":"182","author":"Moodley","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3727\/096368910X543385","article-title":"Human Amnion Epithelial Cells Prevent Bleomycin-Induced Lung Injury and Preserve Lung Function","volume":"20","author":"Murphy","year":"2011","journal-title":"Cell Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3727\/096368912X657657","article-title":"Human Amnion Epithelial Cells Repair Established Lung Injury","volume":"22","author":"Vosdoganes","year":"2013","journal-title":"Cell Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2013.02.011","article-title":"Improved Amino Acid, Bioenergetic Metabolite and Neurotransmitter Profiles following Human Amnion Epithelial Cell Transplant in Intermediate Maple Syrup Urine Disease Mice","volume":"109","author":"Skvorak","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.26150","article-title":"Placental stem cell correction of murine intermediate maple syrup urine disease","volume":"57","author":"Skvorak","year":"2013","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40139-016-0112-8","article-title":"Therapeutic use of human amnion-derived products: Cell-based therapy for liver disease","volume":"4","author":"Gramignoli","year":"2016","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3727\/096368910X504496","article-title":"Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl4-Treated Mice","volume":"19","author":"Manuelpillai","year":"2010","journal-title":"Cell Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10561-012-9337-x","article-title":"Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model","volume":"14","author":"Ricci","year":"2012","journal-title":"Cell Tissue Bank"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/sctm.19-0251","article-title":"Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia","volume":"9","author":"Malhotra","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/sctm.18-0079","article-title":"First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants with Bronchopulmonary Dysplasia: A Safety Study","volume":"7","author":"Lim","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","article-title":"Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells","volume":"26","author":"Parolini","year":"2008","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.humimm.2016.07.002","article-title":"Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease","volume":"77","author":"Strom","year":"2016","journal-title":"Hum. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"172545","DOI":"10.1016\/j.ejphar.2019.172545","article-title":"Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines","volume":"859","author":"Kolanko","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1574888X11308010011","article-title":"Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells","volume":"8","author":"Tee","year":"2013","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.humimm.2008.04.007","article-title":"Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells","volume":"69","author":"Banas","year":"2008","journal-title":"Hum. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4049\/jimmunol.1800432","article-title":"Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations","volume":"202","author":"Morandi","year":"2018","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12015-006-0020-0","article-title":"Amnion-derived pluripotent\/multipotent stem cells","volume":"2","author":"Miki","year":"2006","journal-title":"Stem Cell Rev."},{"key":"ref_27","first-page":"1E.10.1","article-title":"Isolation of Human Amnion Epithelial Cells According to Current Good Manufacturing Procedures","volume":"37","author":"Gramignoli","year":"2016","journal-title":"Curr. Protoc. Stem Cell Boil."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jcyt.2018.10.007","article-title":"Evaluation of different routes of administration and biodistribution of human amnion epithelial cells in mice","volume":"21","author":"Srinivasan","year":"2019","journal-title":"Cytotherapy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.tp.0000231689.44266.ac","article-title":"Human Hepatocyte Transplantation: Worldwide Results","volume":"82","author":"Fisher","year":"2006","journal-title":"Transplantation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000369552","article-title":"Clinical Hepatocyte Transplantation: Practical Limits and Possible Solutions","volume":"54","author":"Gramignoli","year":"2015","journal-title":"Eur. Surg. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: Current status and future perspectives","volume":"83","author":"Iansante","year":"2017","journal-title":"Pediatr. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13287-018-1063-2","article-title":"Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure","volume":"9","author":"Liu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","article-title":"KIR2DL4 (CD158d): An activation receptor for HLA-G","volume":"3","author":"Rajagopalan","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A Human Histocompatibility Leukocyte Antigen (HLA)-G\u2013specific Receptor Expressed on All Natural Killer Cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25602","DOI":"10.18632\/oncotarget.4693","article-title":"A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation","volume":"6","author":"Morandi","year":"2015","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1242\/jcs.00388","article-title":"Isolation of hepatoblasts based on the expression of Dlk\/Pref-1","volume":"116","author":"Tanimizu","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0929-6646(11)60043-0","article-title":"Prevalence of Telomerase Activity in Human Cancer","volume":"110","author":"Chen","year":"2011","journal-title":"J. Formos. Med Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/685267","article-title":"Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP","volume":"2012","author":"Shirvaikar","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1083\/jcb.149.6.1167","article-title":"Cell Migration through Extracellular Matrix","volume":"149","author":"Quaranta","year":"2000","journal-title":"J. Cell Boil."},{"key":"ref_43","first-page":"55","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. et Biophys. Acta (BBA)\u2013Bioenerg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ajmg.1320440430","article-title":"Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells","volume":"44","author":"Bembi","year":"1992","journal-title":"Am. J. Med. Genet."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/7\/1696\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:46Z","timestamp":1760176126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/7\/1696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["cells9071696"],"URL":"https:\/\/doi.org\/10.3390\/cells9071696","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2020,7,15]]}}}